NEW DELHI: UK Pharmaceutical company
AstraZeneca
has admitted that its Covid-19
vaccine
has the potential to cause to a rare side effect called
Thrombosis
with
Thrombocytopenia Syndrome
(
TTS
), as reported by The Telegraph.
AstraZeneca which collaborated with the University of Oxford to create the vaccine is currently dealing with a lawsuit that claims their vaccine has caused deaths and severe harm to those who received it.
Previous year, Jamie Scott, a father of two, took
legal
action after suffering from a blood clot that left him unable to work. Scott said that he developed a “blood clot and a bleed on his brain”, leaving him with a lasting brain injury following his vaccination in April 2021.
According to The Telegraph, Scott’s wife Kate said, “The medical world has acknowledged for a long time that vaccine-induced immune thrombocytopenia and thrombosis (VITT) was caused by the vaccine.”
However, in May 2023, the company informed Scott’s lawyers that they do not acknowledge that TTS is induced by the vaccine on a general level.
Later in the legal document submitted to the High Court the multinational pharmaceutical company said,” “It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known.”
Kate has demanded an apology and fair compensation for their family and other affected families, stating that it took three years for the admission.
She said,”We have the truth on our side, and we are not going to give up.”
As per the report, fifty-one cases have been filed in the High Court, with affected individuals and their families pursuing compensation amounting to an estimated £100 million.
AstraZeneca also collaborated with the Serum Institute of India (SII), the largest vaccine producer globally, to provide the vaccine to the Indian Government.
